Pfizer CEO Quits After Stock Underperforms 97% of S&P

Pfizer CEO Quits After Stock Underperforms 97% of S&P

JB Reed/Bloomberg

Pfizer bought Wyeth in 2009 to add products when the Lipitor cholesterol pill faces generic competition.